Ossiam Has $1.66 Million Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Ossiam raised its position in Healthpeak Properties, Inc. (NYSE:DOC) by 23.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 81,789 shares of the real estate investment trust’s stock after acquiring an additional 15,398 shares during the period. Ossiam’s holdings in Healthpeak Properties were worth $1,658,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Mizuho Bank Ltd. bought a new stake in Healthpeak Properties during the 4th quarter valued at $28,000. Harvest Fund Management Co. Ltd bought a new position in Healthpeak Properties in the 4th quarter valued at about $30,000. Covestor Ltd boosted its stake in Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,152 shares during the last quarter. AdvisorNet Financial Inc increased its holdings in Healthpeak Properties by 34.5% during the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in shares of Healthpeak Properties in the fourth quarter worth approximately $45,000. Institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on DOC. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, April 14th. Wedbush restated an “outperform” rating and set a $24.00 price target on shares of Healthpeak Properties in a report on Friday, April 11th. Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Robert W. Baird cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Finally, Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $23.83.

Healthpeak Properties Stock Performance

NYSE DOC opened at $18.75 on Monday. The company’s 50 day moving average is $19.68 and its 200-day moving average is $20.67. The firm has a market cap of $13.11 billion, a P/E ratio of 53.56, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. Healthpeak Properties, Inc. has a 12-month low of $17.33 and a 12-month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Dividend Announcement

The business also recently announced a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be given a dividend of $0.1017 per share. The ex-dividend date is Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.